Zymedyne Therapeutics
PrivateLast Round
Seed
Nov 6, 2025
Total Funding Raised
$1.13M
Company Overview
Zymedyne Therapeutics is a biotechnology company that develops non-opioid, small-molecule treatments for chronic inflammatory and neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
non-opioid analgesicschronic pain treatmentsmall molecule drugsCav3.2 inhibitorspain managementnon-addictive pain reliefneuropathic paindrug discoverybiotech startupin-silico drug discoverypainkiller alternativesnon-narcotic pain medspre-clinical researchcomputational biologypharma licensing
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zymedyne Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Zymedyne Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 6, 2025 | ||||
| Grant | Nov 6, 2024 | ||||
| Grant | Nov 1, 2024 | ||||
| Grant | Dec 15, 2023 | ||||
| Grant | Jun 3, 2022 | ||||
Grant | Jan 18, 2022 |
Zymedyne Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Macquarie University Incubator | Grant |
| National Research Council Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Alberta Innovates | Grant |
| Innovate Calgary | Grant |
| National Research Council of Canada | Grant |
| University of Calgary | Seed |
Zymedyne Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zymedyne Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersCalgary
Employee Range3
Year Founded2020
Last FundingNov 6, 2025